Novel motif:151: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 15:21, 9 September 2013
name: | motif151_GCCYGTGCMKCW |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0043088 | regulation of Cdc42 GTPase activity | 7.356144e-12 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 5.502993e-10 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 7.018822e-10 |
GO:0060253 | negative regulation of glial cell proliferation | 9.012985e-10 |
GO:0060251 | regulation of glial cell proliferation | 9.650074e-10 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 3.054852e-9 |
GO:0002679 | respiratory burst involved in defense response | 3.751187e-9 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 7.354210e-9 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 1.420285e-8 |
GO:0043966 | histone H3 acetylation | 2.115038e-8 |
GO:0014014 | negative regulation of gliogenesis | 2.762719e-8 |
GO:0043585 | nose morphogenesis | 3.567033e-8 |
GO:0043487 | regulation of RNA stability | 4.519889e-8 |
GO:0019086 | late viral mRNA transcription | 7.210344e-8 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 7.465911e-8 |
GO:0043488 | regulation of mRNA stability | 7.563426e-8 |
GO:0071732 | cellular response to nitric oxide | 9.759904e-8 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 1.042450e-7 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 1.115152e-7 |
GO:0031064 | negative regulation of histone deacetylation | 1.531957e-7 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 2.056336e-7 |
GO:0022011 | myelination in peripheral nervous system | 2.561329e-7 |
GO:0050685 | positive regulation of mRNA processing | 2.671867e-7 |
GO:0035499 | carnosine biosynthetic process | 2.694063e-7 |
GO:0010626 | negative regulation of Schwann cell proliferation | 2.936217e-7 |
GO:0045217 | cell-cell junction maintenance | 3.836901e-7 |
GO:0014037 | Schwann cell differentiation | 3.892858e-7 |
GO:0045064 | T-helper 2 cell differentiation | 3.990234e-7 |
GO:0002315 | marginal zone B cell differentiation | 3.990234e-7 |
GO:0010739 | positive regulation of protein kinase A signaling cascade | 4.356311e-7 |
GO:0002149 | hypochlorous acid biosynthetic process | 4.588061e-7 |
GO:0007296 | vitellogenesis | 4.836617e-7 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 5.408044e-7 |
GO:2000272 | negative regulation of receptor activity | 6.112789e-7 |
GO:0006304 | DNA modification | 8.287977e-7 |
GO:0048561 | establishment of organ orientation | 8.320569e-7 |
GO:0014044 | Schwann cell development | 8.474091e-7 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 9.300668e-7 |
GO:0014807 | regulation of somitogenesis | 1.277190e-6 |
GO:0008078 | mesodermal cell migration | 1.297358e-6 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 1.307797e-6 |
GO:0071956 | cellular component maintenance at cellular level | 1.328805e-6 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 1.627417e-6 |
GO:0032864 | activation of Cdc42 GTPase activity | 1.877820e-6 |
GO:0044258 | intestinal lipid catabolic process | 1.879604e-6 |
GO:0018350 | protein esterification | 1.879604e-6 |
GO:0015891 | siderophore transport | 1.879604e-6 |
GO:0006801 | superoxide metabolic process | 1.920231e-6 |
GO:0018205 | peptidyl-lysine modification | 1.975322e-6 |
GO:0001885 | endothelial cell development | 2.223831e-6 |
GO:0035814 | negative regulation of renal sodium excretion | 2.226170e-6 |
GO:0006853 | carnitine shuttle | 2.340425e-6 |
GO:0071731 | response to nitric oxide | 2.467657e-6 |
GO:0000089 | mitotic metaphase | 3.024666e-6 |
GO:0001886 | endothelial cell morphogenesis | 3.103620e-6 |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 3.126749e-6 |
GO:0032096 | negative regulation of response to food | 3.314011e-6 |
GO:0061014 | positive regulation of mRNA catabolic process | 3.503012e-6 |
GO:0043543 | protein acylation | 4.051996e-6 |
GO:0009264 | deoxyribonucleotide catabolic process | 4.604827e-6 |
GO:0010624 | regulation of Schwann cell proliferation | 4.902528e-6 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 4.957060e-6 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 5.481819e-6 |
GO:0072337 | modified amino acid transport | 5.658447e-6 |
GO:0006285 | base-excision repair, AP site formation | 5.772856e-6 |
GO:0032099 | negative regulation of appetite | 6.821943e-6 |
GO:0021528 | commissural neuron differentiation in spinal cord | 6.890538e-6 |
GO:0050779 | RNA destabilization | 6.930013e-6 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 7.127066e-6 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 7.127934e-6 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 9.165399e-6 |
GO:0006475 | internal protein amino acid acetylation | 9.350735e-6 |
GO:0042474 | middle ear morphogenesis | 9.489559e-6 |
GO:0097152 | mesenchymal cell apoptosis | 9.501187e-6 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 9.501187e-6 |
GO:0060982 | coronary artery morphogenesis | 9.501187e-6 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 1.018263e-5 |
GO:0032312 | regulation of ARF GTPase activity | 1.073130e-5 |
GO:0000093 | mitotic telophase | 1.181881e-5 |
GO:0007386 | compartment pattern specification | 1.253933e-5 |
GO:0061013 | regulation of mRNA catabolic process | 1.262394e-5 |
GO:2000974 | negative regulation of pro-B cell differentiation | 1.269193e-5 |
GO:0031284 | positive regulation of guanylate cyclase activity | 1.329796e-5 |
GO:0034214 | protein hexamerization | 1.368884e-5 |
GO:0045668 | negative regulation of osteoblast differentiation | 1.420962e-5 |
GO:0032383 | regulation of intracellular cholesterol transport | 1.475346e-5 |
GO:0097039 | protein linear polyubiquitination | 1.499739e-5 |
GO:0071472 | cellular response to salt stress | 1.520434e-5 |
GO:0033683 | nucleotide-excision repair, DNA incision | 1.656581e-5 |
GO:0007028 | cytoplasm organization | 1.676742e-5 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 1.720619e-5 |
GO:0006707 | cholesterol catabolic process | 1.724492e-5 |
GO:0042274 | ribosomal small subunit biogenesis | 1.727243e-5 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.792749e-5 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.897574e-5 |
GO:0015879 | carnitine transport | 1.928402e-5 |
GO:2000002 | negative regulation of DNA damage checkpoint | 2.030139e-5 |
GO:0070625 | zymogen granule exocytosis | 2.030139e-5 |
GO:0021551 | central nervous system morphogenesis | 2.030139e-5 |
GO:0021588 | cerebellum formation | 2.030139e-5 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 2.030139e-5 |
GO:0006473 | protein acetylation | 2.153716e-5 |
GO:0042093 | T-helper cell differentiation | 2.303564e-5 |
GO:0043313 | regulation of neutrophil degranulation | 2.353244e-5 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 2.433171e-5 |
GO:0043921 | modulation by host of viral transcription | 2.574664e-5 |
GO:0016188 | synaptic vesicle maturation | 2.728168e-5 |
GO:0031330 | negative regulation of cellular catabolic process | 2.794645e-5 |
GO:0030046 | parallel actin filament bundle assembly | 2.843280e-5 |
GO:0018393 | internal peptidyl-lysine acetylation | 2.850242e-5 |
GO:0033687 | osteoblast proliferation | 3.085997e-5 |
GO:0006449 | regulation of translational termination | 3.128017e-5 |
GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration | 3.240863e-5 |
GO:0010889 | regulation of sequestering of triglyceride | 3.252832e-5 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 3.290319e-5 |
GO:0018394 | peptidyl-lysine acetylation | 3.482717e-5 |
GO:0007023 | post-chaperonin tubulin folding pathway | 3.504132e-5 |
GO:0042053 | regulation of dopamine metabolic process | 3.719477e-5 |
GO:0015887 | pantothenate transmembrane transport | 3.913218e-5 |
GO:0015878 | biotin transport | 3.913218e-5 |
GO:0032526 | response to retinoic acid | 4.015871e-5 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 4.654456e-5 |
GO:0016573 | histone acetylation | 4.654519e-5 |
GO:0034384 | high-density lipoprotein particle clearance | 4.706767e-5 |
GO:0021523 | somatic motor neuron differentiation | 4.706767e-5 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 4.739610e-5 |
GO:0042886 | amide transport | 5.445465e-5 |
GO:0030704 | vitelline membrane formation | 5.696067e-5 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 5.714836e-5 |
GO:0002115 | store-operated calcium entry | 5.717018e-5 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 5.721007e-5 |
GO:0071514 | genetic imprinting | 5.811651e-5 |
GO:0031440 | regulation of mRNA 3'-end processing | 6.011946e-5 |
GO:0045112 | integrin biosynthetic process | 6.037596e-5 |
GO:0001570 | vasculogenesis | 6.082472e-5 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 6.092614e-5 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 6.092614e-5 |
GO:0043353 | enucleate erythrocyte differentiation | 6.162942e-5 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 6.828398e-5 |
GO:0043314 | negative regulation of neutrophil degranulation | 7.337484e-5 |
GO:0051702 | interaction with symbiont | 7.631538e-5 |
GO:0015780 | nucleotide-sugar transport | 7.660177e-5 |
GO:0002268 | follicular dendritic cell differentiation | 8.134654e-5 |
GO:0032108 | negative regulation of response to nutrient levels | 8.653002e-5 |
GO:0051851 | modification by host of symbiont morphology or physiology | 9.519977e-5 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 9.746328e-5 |
GO:0051645 | Golgi localization | 9.796846e-5 |
GO:0042069 | regulation of catecholamine metabolic process | 9.945281e-5 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.017531e-4 |
GO:0033233 | regulation of protein sumoylation | 1.110897e-4 |
GO:0045686 | negative regulation of glial cell differentiation | 1.124386e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 1.149735e-4 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.149735e-4 |
GO:2000077 | negative regulation of type B pancreatic cell development | 1.153233e-4 |
GO:0045007 | depurination | 1.153233e-4 |
GO:0032202 | telomere assembly | 1.185206e-4 |
GO:0032417 | positive regulation of sodium:hydrogen antiporter activity | 1.253529e-4 |
GO:0060711 | labyrinthine layer development | 1.331905e-4 |
GO:0043491 | protein kinase B signaling cascade | 1.365583e-4 |
GO:0034614 | cellular response to reactive oxygen species | 1.429714e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 1.432475e-4 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.443950e-4 |
GO:0060395 | SMAD protein signal transduction | 1.506626e-4 |
GO:0043923 | positive regulation by host of viral transcription | 1.542061e-4 |
GO:0045684 | positive regulation of epidermis development | 1.564851e-4 |
GO:0032012 | regulation of ARF protein signal transduction | 1.573360e-4 |
GO:0051668 | localization within membrane | 1.730188e-4 |
GO:0018022 | peptidyl-lysine methylation | 1.814794e-4 |
GO:0000305 | response to oxygen radical | 1.818337e-4 |
GO:0001892 | embryonic placenta development | 1.870558e-4 |
GO:0021986 | habenula development | 1.872074e-4 |
GO:0034389 | lipid particle organization | 1.950181e-4 |
GO:0051205 | protein insertion into membrane | 2.031538e-4 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 2.078052e-4 |
GO:0006402 | mRNA catabolic process | 2.134306e-4 |
GO:0060484 | lung-associated mesenchyme development | 2.162957e-4 |
GO:0043922 | negative regulation by host of viral transcription | 2.185382e-4 |
GO:0007006 | mitochondrial membrane organization | 2.255363e-4 |
GO:0070904 | transepithelial L-ascorbic acid transport | 2.303082e-4 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 2.328927e-4 |
GO:0070194 | synaptonemal complex disassembly | 2.328927e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 2.426480e-4 |
GO:0090342 | regulation of cell aging | 2.445626e-4 |
GO:0015969 | guanosine tetraphosphate metabolic process | 2.554155e-4 |
GO:0035803 | egg coat formation | 2.554155e-4 |
GO:0009438 | methylglyoxal metabolic process | 2.558982e-4 |
GO:0007020 | microtubule nucleation | 2.590828e-4 |
GO:0000387 | spliceosomal snRNP assembly | 2.595703e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.627453e-4 |
GO:0046015 | regulation of transcription by glucose | 2.671325e-4 |
GO:0031669 | cellular response to nutrient levels | 2.780519e-4 |
GO:0018023 | peptidyl-lysine trimethylation | 2.835803e-4 |
GO:0022009 | central nervous system vasculogenesis | 2.905582e-4 |
GO:0032233 | positive regulation of actin filament bundle assembly | 2.906441e-4 |
GO:0034101 | erythrocyte homeostasis | 3.035873e-4 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 3.057730e-4 |
GO:0010452 | histone H3-K36 methylation | 3.057730e-4 |
GO:0009262 | deoxyribonucleotide metabolic process | 3.114667e-4 |
GO:0015781 | pyrimidine nucleotide-sugar transport | 3.140988e-4 |
GO:0046952 | ketone body catabolic process | 3.342933e-4 |
GO:0010871 | negative regulation of receptor biosynthetic process | 3.366009e-4 |
GO:0000072 | M phase specific microtubule process | 3.433801e-4 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 3.434605e-4 |
GO:0070301 | cellular response to hydrogen peroxide | 3.442411e-4 |
GO:0019430 | removal of superoxide radicals | 3.623848e-4 |
GO:0016125 | sterol metabolic process | 3.726250e-4 |
GO:0015844 | monoamine transport | 3.784076e-4 |
GO:0032933 | SREBP-mediated signaling pathway | 3.965795e-4 |
GO:0031668 | cellular response to extracellular stimulus | 4.116042e-4 |
GO:0003374 | dynamin polymerization involved in mitochondrial fission | 4.154150e-4 |
GO:0090149 | membrane fission involved in mitochondrial fission | 4.154150e-4 |
GO:0072060 | outer medullary collecting duct development | 4.159470e-4 |
GO:0072061 | inner medullary collecting duct development | 4.159470e-4 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 4.159470e-4 |
GO:0071496 | cellular response to external stimulus | 4.347811e-4 |
GO:0019087 | transformation of host cell by virus | 4.409060e-4 |
GO:0030218 | erythrocyte differentiation | 4.475120e-4 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 4.504170e-4 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 4.582227e-4 |
GO:0048549 | positive regulation of pinocytosis | 4.682318e-4 |
GO:0072595 | maintenance of protein localization to organelle | 4.766673e-4 |
GO:0097029 | mature dendritic cell differentiation | 4.910953e-4 |
GO:0071872 | cellular response to epinephrine stimulus | 4.910953e-4 |
GO:0008089 | anterograde axon cargo transport | 4.957669e-4 |
GO:0014013 | regulation of gliogenesis | 5.005450e-4 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 5.058819e-4 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 5.191778e-4 |
GO:0070875 | positive regulation of glycogen metabolic process | 5.201493e-4 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 5.257851e-4 |
GO:0006401 | RNA catabolic process | 5.306244e-4 |
GO:0048845 | venous blood vessel morphogenesis | 5.350469e-4 |
GO:0008589 | regulation of smoothened signaling pathway | 5.543760e-4 |
GO:0010713 | negative regulation of collagen metabolic process | 5.920372e-4 |
GO:0034589 | hydroxyproline transport | 6.053876e-4 |
GO:0015826 | threonine transport | 6.053876e-4 |
GO:0018027 | peptidyl-lysine dimethylation | 6.133603e-4 |
GO:0018208 | peptidyl-proline modification | 6.209433e-4 |
GO:0070873 | regulation of glycogen metabolic process | 6.247426e-4 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 6.270835e-4 |
GO:0071470 | cellular response to osmotic stress | 6.371320e-4 |
GO:0009098 | leucine biosynthetic process | 6.416560e-4 |
GO:0043181 | vacuolar sequestering | 6.416560e-4 |
GO:0006550 | isoleucine catabolic process | 6.416560e-4 |
GO:0005985 | sucrose metabolic process | 6.416560e-4 |
GO:0000023 | maltose metabolic process | 6.416560e-4 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 6.503032e-4 |
GO:0060621 | negative regulation of cholesterol import | 6.578260e-4 |
GO:0015670 | carbon dioxide transport | 6.578260e-4 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 6.702329e-4 |
GO:0000413 | protein peptidyl-prolyl isomerization | 6.702704e-4 |
GO:0045618 | positive regulation of keratinocyte differentiation | 6.805349e-4 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 7.096145e-4 |
GO:0022411 | cellular component disassembly | 7.101533e-4 |
GO:0019083 | viral transcription | 7.300790e-4 |
GO:0071845 | cellular component disassembly at cellular level | 7.342963e-4 |
GO:0009650 | UV protection | 7.515716e-4 |
GO:0007063 | regulation of sister chromatid cohesion | 7.515716e-4 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 7.569442e-4 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 7.627720e-4 |
GO:0032374 | regulation of cholesterol transport | 7.638236e-4 |
GO:0046902 | regulation of mitochondrial membrane permeability | 7.874511e-4 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 8.164396e-4 |
GO:0043249 | erythrocyte maturation | 8.289353e-4 |
GO:0006386 | termination of RNA polymerase III transcription | 8.301793e-4 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 8.301793e-4 |
GO:0045218 | zonula adherens maintenance | 8.356242e-4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 8.398193e-4 |
GO:0045879 | negative regulation of smoothened signaling pathway | 8.589224e-4 |
GO:0043163 | cell envelope organization | 8.903386e-4 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 8.903386e-4 |
GO:0060620 | regulation of cholesterol import | 9.037540e-4 |
GO:0032365 | intracellular lipid transport | 9.122125e-4 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 9.134477e-4 |
GO:0006621 | protein retention in ER lumen | 9.378999e-4 |
GO:0010225 | response to UV-C | 9.378999e-4 |
GO:0071392 | cellular response to estradiol stimulus | 9.401722e-4 |
GO:0032205 | negative regulation of telomere maintenance | 9.436411e-4 |
GO:0035871 | protein K11-linked deubiquitination | 9.538002e-4 |
GO:0043418 | homocysteine catabolic process | 9.538002e-4 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 9.538002e-4 |
GO:0035378 | carbon dioxide transmembrane transport | 9.538002e-4 |
GO:0035377 | transepithelial water transport | 9.538002e-4 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 9.538002e-4 |
GO:0019346 | transsulfuration | 9.538002e-4 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 9.538002e-4 |
GO:0006535 | cysteine biosynthetic process from serine | 9.538002e-4 |
GO:0002089 | lens morphogenesis in camera-type eye | 9.613726e-4 |
GO:0034198 | cellular response to amino acid starvation | 9.819075e-4 |
GO:0008203 | cholesterol metabolic process | 9.839541e-4 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 1.000481e-3 |
GO:0035269 | protein O-linked mannosylation | 1.000481e-3 |
GO:0006083 | acetate metabolic process | 1.000481e-3 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 1.000481e-3 |
GO:0019242 | methylglyoxal biosynthetic process | 1.000481e-3 |
GO:0015669 | gas transport | 1.011206e-3 |
GO:0006457 | protein folding | 1.032007e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 1.034423e-3 |
GO:0042074 | cell migration involved in gastrulation | 1.043756e-3 |
GO:0030490 | maturation of SSU-rRNA | 1.047830e-3 |
GO:0050881 | musculoskeletal movement | 1.049147e-3 |
GO:0007635 | chemosensory behavior | 1.051218e-3 |
GO:0071705 | nitrogen compound transport | 1.058354e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.058902e-3 |
GO:0000303 | response to superoxide | 1.059215e-3 |
GO:0070483 | detection of hypoxia | 1.073350e-3 |
GO:2000209 | regulation of anoikis | 1.075937e-3 |
GO:0019448 | L-cysteine catabolic process | 1.088992e-3 |
GO:0006244 | pyrimidine nucleotide catabolic process | 1.089676e-3 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.092598e-3 |
GO:0015695 | organic cation transport | 1.093261e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 1.107485e-3 |
GO:0018916 | nitrobenzene metabolic process | 1.107485e-3 |
GO:0070831 | basement membrane assembly | 1.107485e-3 |
GO:0046655 | folic acid metabolic process | 1.109021e-3 |
GO:0048710 | regulation of astrocyte differentiation | 1.129142e-3 |
GO:0060267 | positive regulation of respiratory burst | 1.140023e-3 |
GO:0060674 | placenta blood vessel development | 1.140358e-3 |
GO:0032897 | negative regulation of viral transcription | 1.168038e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 1.178277e-3 |
GO:0035090 | maintenance of apical/basal cell polarity | 1.187099e-3 |
GO:0070345 | negative regulation of fat cell proliferation | 1.187099e-3 |
GO:0051323 | metaphase | 1.232213e-3 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 1.233042e-3 |
GO:0032094 | response to food | 1.256618e-3 |
GO:0003148 | outflow tract septum morphogenesis | 1.270542e-3 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.297820e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 1.301898e-3 |
GO:0048255 | mRNA stabilization | 1.307578e-3 |
GO:0010890 | positive regulation of sequestering of triglyceride | 1.346766e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 1.380020e-3 |
GO:0060038 | cardiac muscle cell proliferation | 1.474370e-3 |
GO:0031365 | N-terminal protein amino acid modification | 1.482542e-3 |
GO:0090239 | regulation of histone H4 acetylation | 1.512655e-3 |
GO:0010216 | maintenance of DNA methylation | 1.512655e-3 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 1.529064e-3 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 1.529574e-3 |
GO:0021512 | spinal cord anterior/posterior patterning | 1.529574e-3 |
GO:0015761 | mannose transport | 1.529574e-3 |
GO:0019413 | acetate biosynthetic process | 1.529574e-3 |
GO:0019542 | propionate biosynthetic process | 1.529574e-3 |
GO:0060708 | spongiotrophoblast differentiation | 1.582198e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.615641e-3 |
GO:0045109 | intermediate filament organization | 1.628820e-3 |
GO:0002335 | mature B cell differentiation | 1.645290e-3 |
GO:0030851 | granulocyte differentiation | 1.654327e-3 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 1.662258e-3 |
GO:0009440 | cyanate catabolic process | 1.673698e-3 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 1.688211e-3 |
GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 1.688211e-3 |
GO:0032423 | regulation of mismatch repair | 1.704301e-3 |
GO:0034227 | tRNA thio-modification | 1.714773e-3 |
GO:0002098 | tRNA wobble uridine modification | 1.714773e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 1.719685e-3 |
GO:0045006 | DNA deamination | 1.748823e-3 |
GO:0042088 | T-helper 1 type immune response | 1.783401e-3 |
GO:0051965 | positive regulation of synapse assembly | 1.787345e-3 |
GO:0060669 | embryonic placenta morphogenesis | 1.815513e-3 |
GO:0006415 | translational termination | 1.827503e-3 |
GO:0009071 | serine family amino acid catabolic process | 1.847399e-3 |
GO:0060789 | hair follicle placode formation | 1.862034e-3 |
GO:0022027 | interkinetic nuclear migration | 1.862034e-3 |
GO:0031282 | regulation of guanylate cyclase activity | 1.889237e-3 |
GO:0000076 | DNA replication checkpoint | 1.920650e-3 |
GO:0019088 | immortalization of host cell by virus | 1.929124e-3 |
GO:0006231 | dTMP biosynthetic process | 1.929124e-3 |
GO:0008616 | queuosine biosynthetic process | 1.929124e-3 |
GO:0002002 | regulation of angiotensin levels in blood | 1.953283e-3 |
GO:0032329 | serine transport | 2.071513e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 2.085348e-3 |
GO:0006306 | DNA methylation | 2.086576e-3 |
GO:0060419 | heart growth | 2.132805e-3 |
GO:0042942 | D-serine transport | 2.136946e-3 |
GO:0043985 | histone H4-R3 methylation | 2.164961e-3 |
GO:0055017 | cardiac muscle tissue growth | 2.195518e-3 |
GO:0060977 | coronary vasculature morphogenesis | 2.217649e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.217649e-3 |
GO:0018105 | peptidyl-serine phosphorylation | 2.231498e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 2.238859e-3 |
GO:0032862 | activation of Rho GTPase activity | 2.239155e-3 |
GO:0072526 | pyridine-containing compound catabolic process | 2.260804e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 2.292896e-3 |
GO:0060052 | neurofilament cytoskeleton organization | 2.310839e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 2.311327e-3 |
GO:0019730 | antimicrobial humoral response | 2.335999e-3 |
GO:0006991 | response to sterol depletion | 2.338671e-3 |
GO:0040030 | regulation of molecular function, epigenetic | 2.362939e-3 |
GO:0010469 | regulation of receptor activity | 2.474439e-3 |
GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 2.482340e-3 |
GO:0072109 | glomerular mesangium development | 2.482541e-3 |
GO:0071356 | cellular response to tumor necrosis factor | 2.532176e-3 |
GO:0048339 | paraxial mesoderm development | 2.550448e-3 |
GO:2000737 | negative regulation of stem cell differentiation | 2.557662e-3 |
GO:0060707 | trophoblast giant cell differentiation | 2.564525e-3 |
GO:0032765 | positive regulation of mast cell cytokine production | 2.640497e-3 |
GO:0060242 | contact inhibition | 2.640497e-3 |
GO:0021644 | vagus nerve morphogenesis | 2.640497e-3 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.656101e-3 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 2.715563e-3 |
GO:0090344 | negative regulation of cell aging | 2.728011e-3 |
GO:0005979 | regulation of glycogen biosynthetic process | 2.729495e-3 |
GO:0051567 | histone H3-K9 methylation | 2.752784e-3 |
GO:0090241 | negative regulation of histone H4 acetylation | 2.752784e-3 |
GO:0031953 | negative regulation of protein autophosphorylation | 2.784707e-3 |
GO:0001300 | chronological cell aging | 2.786673e-3 |
GO:0032682 | negative regulation of chemokine production | 2.815488e-3 |
GO:0097150 | neuronal stem cell maintenance | 2.852321e-3 |
GO:0043586 | tongue development | 2.854629e-3 |
GO:0035601 | protein deacylation | 2.871120e-3 |
GO:0033235 | positive regulation of protein sumoylation | 2.894219e-3 |
GO:0051414 | response to cortisol stimulus | 2.925184e-3 |
GO:0071476 | cellular hypotonic response | 2.948654e-3 |
GO:0046340 | diacylglycerol catabolic process | 2.948654e-3 |
GO:0032098 | regulation of appetite | 2.984485e-3 |
GO:0031670 | cellular response to nutrient | 3.035072e-3 |
GO:0016569 | covalent chromatin modification | 3.038706e-3 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 3.049945e-3 |
GO:0006706 | steroid catabolic process | 3.069303e-3 |
GO:0034380 | high-density lipoprotein particle assembly | 3.094635e-3 |
GO:0090140 | regulation of mitochondrial fission | 3.134041e-3 |
GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation | 3.138249e-3 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 3.138249e-3 |
GO:0060216 | definitive hemopoiesis | 3.157033e-3 |
GO:0070327 | thyroid hormone transport | 3.170872e-3 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 3.204954e-3 |
GO:0006476 | protein deacetylation | 3.226254e-3 |
GO:0006826 | iron ion transport | 3.250673e-3 |
GO:0045651 | positive regulation of macrophage differentiation | 3.252170e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 3.290090e-3 |
GO:0010544 | negative regulation of platelet activation | 3.304868e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 3.365205e-3 |
GO:0030423 | targeting of mRNA for destruction involved in RNA interference | 3.365251e-3 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 3.503904e-3 |
GO:0051958 | methotrexate transport | 3.503904e-3 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.510910e-3 |
GO:0060872 | semicircular canal development | 3.517929e-3 |
GO:0021526 | medial motor column neuron differentiation | 3.521043e-3 |
GO:0002309 | T cell proliferation involved in immune response | 3.521043e-3 |
GO:0030823 | regulation of cGMP metabolic process | 3.536936e-3 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 3.584565e-3 |
GO:0010608 | posttranscriptional regulation of gene expression | 3.584641e-3 |
GO:0045806 | negative regulation of endocytosis | 3.650162e-3 |
GO:0030157 | pancreatic juice secretion | 3.652762e-3 |
GO:0071477 | cellular hypotonic salinity response | 3.652885e-3 |
GO:0060456 | positive regulation of digestive system process | 3.656974e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 3.687083e-3 |
GO:0031017 | exocrine pancreas development | 3.716192e-3 |
GO:0016570 | histone modification | 3.736498e-3 |
GO:0042491 | auditory receptor cell differentiation | 3.772067e-3 |
GO:0015696 | ammonium transport | 3.777329e-3 |
GO:0032008 | positive regulation of TOR signaling cascade | 3.789078e-3 |
GO:0071879 | positive regulation of adrenergic receptor signaling pathway | 3.875767e-3 |
GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 3.875767e-3 |
GO:0006742 | NADP catabolic process | 3.875767e-3 |
GO:0010905 | negative regulation of UDP-glucose catabolic process | 3.875767e-3 |
GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 3.939468e-3 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 3.939468e-3 |
GO:0018293 | protein-FAD linkage | 3.939468e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 3.939468e-3 |
GO:0033700 | phospholipid efflux | 3.948105e-3 |
GO:0072668 | tubulin complex biogenesis | 4.020388e-3 |
GO:0045008 | depyrimidination | 4.028046e-3 |
GO:0048712 | negative regulation of astrocyte differentiation | 4.088558e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 4.107337e-3 |
GO:0010891 | negative regulation of sequestering of triglyceride | 4.112729e-3 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 4.116698e-3 |
GO:0032793 | positive regulation of CREB transcription factor activity | 4.134495e-3 |
GO:0043300 | regulation of leukocyte degranulation | 4.142130e-3 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 4.192730e-3 |
GO:0090251 | protein localization involved in establishment of planar polarity | 4.213141e-3 |
GO:0060837 | blood vessel endothelial cell differentiation | 4.213141e-3 |
GO:0019402 | galactitol metabolic process | 4.213141e-3 |
GO:0060023 | soft palate development | 4.218544e-3 |
GO:0051457 | maintenance of protein location in nucleus | 4.248919e-3 |
GO:0009635 | response to herbicide | 4.313467e-3 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 4.320282e-3 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 4.333887e-3 |
GO:0033002 | muscle cell proliferation | 4.363811e-3 |
GO:0014898 | cardiac muscle hypertrophy in response to stress | 4.371381e-3 |
GO:0016575 | histone deacetylation | 4.433437e-3 |
GO:0072553 | terminal button organization | 4.434784e-3 |
GO:0060981 | cell migration involved in coronary angiogenesis | 4.434784e-3 |
GO:0071670 | smooth muscle cell chemotaxis | 4.434784e-3 |
GO:0002522 | leukocyte migration involved in immune response | 4.434784e-3 |
GO:0000088 | mitotic prophase | 4.434784e-3 |
GO:0035623 | renal glucose absorption | 4.434784e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 4.442300e-3 |
GO:0072488 | ammonium transmembrane transport | 4.442300e-3 |
GO:0009153 | purine deoxyribonucleotide biosynthetic process | 4.442300e-3 |
GO:0051684 | maintenance of Golgi location | 4.506300e-3 |
GO:0035665 | TIRAP-dependent toll-like receptor 4 signaling pathway | 4.506300e-3 |
GO:0090321 | positive regulation of chylomicron remnant clearance | 4.506300e-3 |
GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 4.506300e-3 |
GO:0010509 | polyamine homeostasis | 4.506300e-3 |
GO:0032738 | positive regulation of interleukin-15 production | 4.506300e-3 |
GO:0032853 | positive regulation of Ran GTPase activity | 4.506300e-3 |
GO:0003300 | cardiac muscle hypertrophy | 4.576314e-3 |
GO:0001302 | replicative cell aging | 4.655059e-3 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 4.693181e-3 |
GO:2000297 | negative regulation of synapse maturation | 4.693181e-3 |
GO:0050872 | white fat cell differentiation | 4.693429e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 2.661097e-9 |
GO:0034447 | very-low-density lipoprotein particle clearance | 2.290557e-7 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 2.635961e-7 |
GO:0048305 | immunoglobulin secretion | 4.529390e-7 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.090050e-7 |
GO:0061028 | establishment of endothelial barrier | 2.109206e-6 |
GO:0014045 | establishment of endothelial blood-brain barrier | 2.911851e-6 |
GO:0050685 | positive regulation of mRNA processing | 5.710661e-6 |
GO:0051583 | dopamine uptake | 6.697780e-6 |
GO:0031440 | regulation of mRNA 3'-end processing | 7.296857e-6 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 9.729041e-6 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.138656e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.618344e-5 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 1.805479e-5 |
GO:0006654 | phosphatidic acid biosynthetic process | 2.126386e-5 |
GO:0019285 | glycine betaine biosynthetic process from choline | 3.421116e-5 |
GO:0048535 | lymph node development | 3.546939e-5 |
GO:0022009 | central nervous system vasculogenesis | 3.696797e-5 |
GO:0018193 | peptidyl-amino acid modification | 3.895113e-5 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 4.287873e-5 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 4.565470e-5 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 4.770877e-5 |
GO:0010155 | regulation of proton transport | 4.778101e-5 |
GO:0000578 | embryonic axis specification | 5.213550e-5 |
GO:0042398 | cellular modified amino acid biosynthetic process | 5.364625e-5 |
GO:0001885 | endothelial cell development | 6.612739e-5 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 6.615998e-5 |
GO:0018293 | protein-FAD linkage | 6.615998e-5 |
GO:0001579 | medium-chain fatty acid transport | 6.615998e-5 |
GO:0006611 | protein export from nucleus | 7.314656e-5 |
GO:0001777 | T cell homeostatic proliferation | 7.346620e-5 |
GO:0034214 | protein hexamerization | 7.567434e-5 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 8.413085e-5 |
GO:0070286 | axonemal dynein complex assembly | 8.413085e-5 |
GO:0002407 | dendritic cell chemotaxis | 9.482101e-5 |
GO:0060896 | neural plate pattern specification | 9.868546e-5 |
GO:0090234 | regulation of kinetochore assembly | 9.998512e-5 |
GO:0090169 | regulation of spindle assembly | 9.998512e-5 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.060981e-4 |
GO:0002352 | B cell negative selection | 1.097534e-4 |
GO:0061014 | positive regulation of mRNA catabolic process | 1.152837e-4 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.405832e-4 |
GO:0010891 | negative regulation of sequestering of triglyceride | 1.455860e-4 |
GO:0001963 | synaptic transmission, dopaminergic | 1.626053e-4 |
GO:0032776 | DNA methylation on cytosine | 1.668467e-4 |
GO:0070316 | regulation of G0 to G1 transition | 1.859995e-4 |
GO:0001570 | vasculogenesis | 2.066668e-4 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 2.080792e-4 |
GO:2000781 | positive regulation of double-strand break repair | 2.203187e-4 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 2.203187e-4 |
GO:0072610 | interleukin-12 secretion | 2.488309e-4 |
GO:0097022 | lymphocyte migration into lymph node | 2.488309e-4 |
GO:0034441 | plasma lipoprotein particle oxidation | 2.488309e-4 |
GO:0002077 | acrosome matrix dispersal | 2.489881e-4 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 2.544649e-4 |
GO:0034983 | peptidyl-lysine deacetylation | 2.638117e-4 |
GO:0071242 | cellular response to ammonium ion | 2.721281e-4 |
GO:0018105 | peptidyl-serine phosphorylation | 2.780428e-4 |
GO:0046849 | bone remodeling | 2.943084e-4 |
GO:0045920 | negative regulation of exocytosis | 3.231981e-4 |
GO:0032239 | regulation of nucleobase-containing compound transport | 3.526937e-4 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 3.526937e-4 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 3.526937e-4 |
GO:0070232 | regulation of T cell apoptosis | 3.569318e-4 |
GO:0051341 | regulation of oxidoreductase activity | 3.611115e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 3.698126e-4 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 3.813766e-4 |
GO:0043301 | negative regulation of leukocyte degranulation | 4.047987e-4 |
GO:0051168 | nuclear export | 4.311635e-4 |
GO:0002268 | follicular dendritic cell differentiation | 4.553901e-4 |
GO:0051204 | protein insertion into mitochondrial membrane | 4.601453e-4 |
GO:0043587 | tongue morphogenesis | 4.682993e-4 |
GO:0006513 | protein monoubiquitination | 4.961587e-4 |
GO:0097026 | dendritic cell dendrite assembly | 5.164549e-4 |
GO:0043314 | negative regulation of neutrophil degranulation | 5.275704e-4 |
GO:0085020 | protein K6-linked ubiquitination | 5.412185e-4 |
GO:0018209 | peptidyl-serine modification | 5.792113e-4 |
GO:0033523 | histone H2B ubiquitination | 5.874906e-4 |
GO:0051865 | protein autoubiquitination | 5.885391e-4 |
GO:0045446 | endothelial cell differentiation | 5.956307e-4 |
GO:0021999 | neural plate anterior/posterior regionalization | 6.011333e-4 |
GO:0003158 | endothelium development | 6.022585e-4 |
GO:0035725 | sodium ion transmembrane transport | 6.311857e-4 |
GO:0002897 | positive regulation of central B cell tolerance induction | 6.579900e-4 |
GO:0002508 | central tolerance induction | 6.579900e-4 |
GO:0033590 | response to cobalamin | 6.628096e-4 |
GO:0002635 | negative regulation of germinal center formation | 6.628096e-4 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 6.706325e-4 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 6.788472e-4 |
GO:0097107 | postsynaptic density assembly | 6.788472e-4 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 6.788472e-4 |
GO:0046604 | positive regulation of mitotic centrosome separation | 7.336667e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 7.336667e-4 |
GO:0035234 | germ cell programmed cell death | 7.659839e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 7.821171e-4 |
GO:0051135 | positive regulation of NK T cell activation | 7.845519e-4 |
GO:0006346 | methylation-dependent chromatin silencing | 7.851798e-4 |
GO:0090083 | regulation of inclusion body assembly | 7.851798e-4 |
GO:0070542 | response to fatty acid | 8.597188e-4 |
GO:0072061 | inner medullary collecting duct development | 8.614367e-4 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 8.614367e-4 |
GO:0072060 | outer medullary collecting duct development | 8.614367e-4 |
GO:0071870 | cellular response to catecholamine stimulus | 9.074814e-4 |
GO:0021533 | cell differentiation in hindbrain | 9.569133e-4 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 9.950235e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 9.950235e-4 |
GO:0016539 | intein-mediated protein splicing | 9.950235e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 9.950235e-4 |
GO:0042149 | cellular response to glucose starvation | 1.029661e-3 |
GO:0006099 | tricarboxylic acid cycle | 1.035341e-3 |
GO:0016242 | negative regulation of macroautophagy | 1.089774e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.113296e-3 |
GO:0060897 | neural plate regionalization | 1.122141e-3 |
GO:0015851 | nucleobase transport | 1.122141e-3 |
GO:0009880 | embryonic pattern specification | 1.150335e-3 |
GO:0072074 | kidney mesenchyme development | 1.213369e-3 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.221327e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 1.227795e-3 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.288842e-3 |
GO:0021587 | cerebellum morphogenesis | 1.293494e-3 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 1.299430e-3 |
GO:0006844 | acyl carnitine transport | 1.299430e-3 |
GO:0060299 | negative regulation of sarcomere organization | 1.299430e-3 |
GO:0046330 | positive regulation of JNK cascade | 1.357462e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 1.368707e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.384502e-3 |
GO:0090026 | positive regulation of monocyte chemotaxis | 1.385576e-3 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 1.444173e-3 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 1.444173e-3 |
GO:0015844 | monoamine transport | 1.453669e-3 |
GO:0006658 | phosphatidylserine metabolic process | 1.477623e-3 |
GO:0006808 | regulation of nitrogen utilization | 1.497267e-3 |
GO:0060674 | placenta blood vessel development | 1.514272e-3 |
GO:0044253 | positive regulation of multicellular organismal metabolic process | 1.559663e-3 |
GO:0043313 | regulation of neutrophil degranulation | 1.578860e-3 |
GO:0008589 | regulation of smoothened signaling pathway | 1.592005e-3 |
GO:0070368 | positive regulation of hepatocyte differentiation | 1.602608e-3 |
GO:0010661 | positive regulation of muscle cell apoptosis | 1.615782e-3 |
GO:0046847 | filopodium assembly | 1.641597e-3 |
GO:0045792 | negative regulation of cell size | 1.676583e-3 |
GO:0090045 | positive regulation of deacetylase activity | 1.680495e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.680495e-3 |
GO:0046602 | regulation of mitotic centrosome separation | 1.705699e-3 |
GO:0019264 | glycine biosynthetic process from serine | 1.705699e-3 |
GO:0061077 | chaperone-mediated protein folding | 1.713848e-3 |
GO:0072205 | metanephric collecting duct development | 1.759186e-3 |
GO:0016241 | regulation of macroautophagy | 1.795059e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 1.795059e-3 |
GO:0009109 | coenzyme catabolic process | 1.808925e-3 |
GO:0043543 | protein acylation | 1.865292e-3 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 1.882760e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.908949e-3 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 1.954547e-3 |
GO:0050779 | RNA destabilization | 1.954547e-3 |
GO:0010887 | negative regulation of cholesterol storage | 1.985972e-3 |
GO:0033004 | negative regulation of mast cell activation | 2.049721e-3 |
GO:0032855 | positive regulation of Rac GTPase activity | 2.087642e-3 |
GO:0045880 | positive regulation of smoothened signaling pathway | 2.105972e-3 |
GO:0046341 | CDP-diacylglycerol metabolic process | 2.110232e-3 |
GO:0015684 | ferrous iron transport | 2.150545e-3 |
GO:0006405 | RNA export from nucleus | 2.207542e-3 |
GO:0050718 | positive regulation of interleukin-1 beta secretion | 2.293723e-3 |
GO:0018210 | peptidyl-threonine modification | 2.352101e-3 |
GO:0002649 | regulation of tolerance induction to self antigen | 2.405004e-3 |
GO:0048239 | negative regulation of DNA recombination at telomere | 2.443079e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 2.443079e-3 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 2.443079e-3 |
GO:0002525 | acute inflammatory response to non-antigenic stimulus | 2.443079e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 2.443079e-3 |
GO:0030035 | microspike assembly | 2.577200e-3 |
GO:0072075 | metanephric mesenchyme development | 2.699919e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 2.751229e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 2.755317e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 2.761184e-3 |
GO:0006406 | mRNA export from nucleus | 2.839837e-3 |
GO:0051984 | positive regulation of chromosome segregation | 2.850069e-3 |
GO:0006184 | GTP catabolic process | 2.921246e-3 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 2.935318e-3 |
GO:0045879 | negative regulation of smoothened signaling pathway | 2.952860e-3 |
GO:0090399 | replicative senescence | 2.978266e-3 |
GO:0061205 | paramesonephric duct development | 2.981500e-3 |
GO:0045184 | establishment of protein localization | 3.074580e-3 |
GO:2000744 | positive regulation of anterior head development | 3.076814e-3 |
GO:0045905 | positive regulation of translational termination | 3.076814e-3 |
GO:0006452 | translational frameshifting | 3.076814e-3 |
GO:0045901 | positive regulation of translational elongation | 3.076814e-3 |
GO:0032933 | SREBP-mediated signaling pathway | 3.194845e-3 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 3.264894e-3 |
GO:0007144 | female meiosis I | 3.264894e-3 |
GO:0016575 | histone deacetylation | 3.278841e-3 |
GO:0002339 | B cell selection | 3.332321e-3 |
GO:0001977 | renal system process involved in regulation of blood volume | 3.358126e-3 |
GO:0051323 | metaphase | 3.385224e-3 |
GO:0070243 | regulation of thymocyte apoptosis | 3.522156e-3 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.600583e-3 |
GO:0045660 | positive regulation of neutrophil differentiation | 3.600583e-3 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 3.600583e-3 |
GO:0070318 | positive regulation of G0 to G1 transition | 3.671524e-3 |
GO:0009107 | lipoate biosynthetic process | 3.683791e-3 |
GO:0045210 | FasL biosynthetic process | 3.683791e-3 |
GO:0006526 | arginine biosynthetic process | 3.683791e-3 |
GO:0060385 | axonogenesis involved in innervation | 3.813755e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 3.862083e-3 |
GO:0035640 | exploration behavior | 3.925205e-3 |
GO:0006837 | serotonin transport | 3.953830e-3 |
GO:0014015 | positive regulation of gliogenesis | 4.032675e-3 |
GO:2000543 | positive regulation of gastrulation | 4.033346e-3 |
GO:0045175 | basal protein localization | 4.063044e-3 |
GO:2000412 | positive regulation of thymocyte migration | 4.152397e-3 |
GO:0002518 | lymphocyte chemotaxis across high endothelial venule | 4.152397e-3 |
GO:0006449 | regulation of translational termination | 4.152397e-3 |
GO:0015670 | carbon dioxide transport | 4.288765e-3 |
GO:2000779 | regulation of double-strand break repair | 4.305792e-3 |
GO:0032768 | regulation of monooxygenase activity | 4.318292e-3 |
GO:0015724 | formate transport | 4.319670e-3 |
GO:0015876 | acetyl-CoA transport | 4.319670e-3 |
GO:0061302 | smooth muscle cell-matrix adhesion | 4.322386e-3 |
GO:0000053 | argininosuccinate metabolic process | 4.322386e-3 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 4.354763e-3 |
GO:0015780 | nucleotide-sugar transport | 4.354763e-3 |
GO:0046958 | nonassociative learning | 4.370851e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 4.370851e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 4.383420e-3 |
GO:0015872 | dopamine transport | 4.548746e-3 |
GO:0009141 | nucleoside triphosphate metabolic process | 4.572476e-3 |
GO:0010721 | negative regulation of cell development | 4.633522e-3 |
GO:0032094 | response to food | 4.677945e-3 |
GO:0048368 | lateral mesoderm development | 4.680827e-3 |
GO:0006863 | purine base transport | 4.680827e-3 |
GO:0001909 | leukocyte mediated cytotoxicity | 4.707662e-3 |
GO:0060026 | convergent extension | 4.826295e-3 |
GO:0006413 | translational initiation | 4.895267e-3 |
GO:0030835 | negative regulation of actin filament depolymerization | 4.971590e-3 |
GO:0043503 | skeletal muscle fiber adaptation | 4.975495e-3 |
GO:0051588 | regulation of neurotransmitter transport | 4.985242e-3 |
GO:0060458 | right lung development | 5.014516e-3 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 5.014516e-3 |
GO:0019348 | dolichol metabolic process | 5.014516e-3 |
GO:0002036 | regulation of L-glutamate transport | 5.014516e-3 |
GO:0045602 | negative regulation of endothelial cell differentiation | 5.014516e-3 |
GO:0051354 | negative regulation of oxidoreductase activity | 5.028848e-3 |
GO:0032967 | positive regulation of collagen biosynthetic process | 5.028848e-3 |
GO:0060439 | trachea morphogenesis | 5.057367e-3 |
GO:0010464 | regulation of mesenchymal cell proliferation | 5.132800e-3 |
GO:0046831 | regulation of RNA export from nucleus | 5.186436e-3 |
GO:0072488 | ammonium transmembrane transport | 5.208980e-3 |
GO:0018345 | protein palmitoylation | 5.251101e-3 |
GO:0051353 | positive regulation of oxidoreductase activity | 5.280607e-3 |
GO:0016567 | protein ubiquitination | 5.292740e-3 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 5.301335e-3 |
GO:0060837 | blood vessel endothelial cell differentiation | 5.338066e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 5.391006e-3 |
GO:0001840 | neural plate development | 5.393652e-3 |
GO:0050768 | negative regulation of neurogenesis | 5.403102e-3 |
GO:0010889 | regulation of sequestering of triglyceride | 5.475156e-3 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 5.540818e-3 |
GO:0006282 | regulation of DNA repair | 5.637680e-3 |
GO:0046590 | embryonic leg morphogenesis | 5.669607e-3 |
GO:0033158 | regulation of protein import into nucleus, translocation | 5.734087e-3 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 5.845391e-3 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 5.845391e-3 |
GO:0007257 | activation of JUN kinase activity | 5.950168e-3 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 6.038717e-3 |
GO:0070932 | histone H3 deacetylation | 6.055104e-3 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 6.055104e-3 |
GO:0035444 | nickel ion transmembrane transport | 6.055104e-3 |
GO:0032769 | negative regulation of monooxygenase activity | 6.060253e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 6.126028e-3 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 6.126028e-3 |
GO:0001556 | oocyte maturation | 6.215469e-3 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 6.332357e-3 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 6.332357e-3 |
GO:0045217 | cell-cell junction maintenance | 6.423296e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 6.440227e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 6.440227e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 6.440227e-3 |
GO:0018205 | peptidyl-lysine modification | 6.730757e-3 |
GO:0048793 | pronephros development | 6.772985e-3 |
GO:0060712 | spongiotrophoblast layer development | 6.772985e-3 |
GO:0009261 | ribonucleotide catabolic process | 6.775623e-3 |
GO:0070245 | positive regulation of thymocyte apoptosis | 6.780360e-3 |
GO:0006687 | glycosphingolipid metabolic process | 6.791768e-3 |
GO:0070234 | positive regulation of T cell apoptosis | 6.943412e-3 |
GO:0021575 | hindbrain morphogenesis | 6.978715e-3 |
GO:0032847 | regulation of cellular pH reduction | 6.993843e-3 |
GO:0010869 | regulation of receptor biosynthetic process | 7.037549e-3 |
GO:0043491 | protein kinase B signaling cascade | 7.092265e-3 |
GO:0015074 | DNA integration | 7.165297e-3 |
GO:0006577 | betaine metabolic process | 7.165297e-3 |
GO:0051030 | snRNA transport | 7.188121e-3 |
GO:0006998 | nuclear envelope organization | 7.228431e-3 |
GO:0046039 | GTP metabolic process | 7.274178e-3 |
GO:0021997 | neural plate axis specification | 7.309656e-3 |
GO:0016559 | peroxisome fission | 7.309656e-3 |
GO:0000089 | mitotic metaphase | 7.309656e-3 |
GO:0006551 | leucine metabolic process | 7.309656e-3 |
GO:0032849 | positive regulation of cellular pH reduction | 7.335210e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 7.392849e-3 |
GO:0046356 | acetyl-CoA catabolic process | 7.557398e-3 |
GO:0072054 | renal outer medulla development | 7.705628e-3 |
GO:2000015 | regulation of determination of dorsal identity | 7.705628e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 7.705628e-3 |
GO:0006370 | mRNA capping | 7.705628e-3 |
GO:0044091 | membrane biogenesis | 7.705628e-3 |
GO:0006657 | CDP-choline pathway | 7.735944e-3 |
GO:0001768 | establishment of T cell polarity | 7.735944e-3 |
GO:0006663 | platelet activating factor biosynthetic process | 7.830529e-3 |
GO:2000426 | negative regulation of apoptotic cell clearance | 7.908119e-3 |
GO:0070585 | protein localization in mitochondrion | 7.990445e-3 |
GO:0005981 | regulation of glycogen catabolic process | 8.128393e-3 |
GO:0070317 | negative regulation of G0 to G1 transition | 8.135185e-3 |
GO:0080164 | regulation of nitric oxide metabolic process | 8.135185e-3 |
GO:0045234 | protein palmitoleylation | 8.135185e-3 |
GO:0035502 | metanephric ureteric bud development | 8.135185e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 8.135185e-3 |
GO:0034474 | U2 snRNA 3'-end processing | 8.135185e-3 |
GO:0006948 | induction by virus of host cell-cell fusion | 8.135185e-3 |
GO:0015031 | protein transport | 8.294855e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 8.351632e-3 |
GO:0018364 | peptidyl-glutamine methylation | 8.351632e-3 |
GO:0016191 | synaptic vesicle uncoating | 8.351632e-3 |
GO:0044246 | regulation of multicellular organismal metabolic process | 8.497181e-3 |
GO:0033037 | polysaccharide localization | 8.517657e-3 |
GO:0021681 | cerebellar granular layer development | 8.556370e-3 |
GO:0021548 | pons development | 8.605189e-3 |
GO:0009306 | protein secretion | 8.610814e-3 |
GO:0033036 | macromolecule localization | 8.615438e-3 |
GO:0051586 | positive regulation of dopamine uptake | 8.819318e-3 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 8.918100e-3 |
GO:0002663 | positive regulation of B cell tolerance induction | 8.918100e-3 |
GO:0021702 | cerebellar Purkinje cell differentiation | 8.918494e-3 |
GO:0048477 | oogenesis | 8.942713e-3 |
GO:0060534 | trachea cartilage development | 9.057797e-3 |
GO:0009154 | purine ribonucleotide catabolic process | 9.063432e-3 |
GO:0046605 | regulation of centrosome cycle | 9.236622e-3 |
GO:0060017 | parathyroid gland development | 9.319255e-3 |
GO:0051823 | regulation of synapse structural plasticity | 9.319255e-3 |
GO:0090224 | regulation of spindle organization | 9.321390e-3 |
GO:0051584 | regulation of dopamine uptake | 9.321390e-3 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 9.365837e-3 |
GO:0072203 | cell proliferation involved in metanephros development | 9.372694e-3 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 9.536013e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 9.555759e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 9.555759e-3 |
GO:0006713 | glucocorticoid catabolic process | 9.555759e-3 |
GO:0022417 | protein maturation by protein folding | 9.555759e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 9.555759e-3 |
GO:0032277 | negative regulation of gonadotropin secretion | 9.641936e-3 |
GO:0018094 | protein polyglycylation | 9.641936e-3 |
GO:0051187 | cofactor catabolic process | 1.007678e-2 |
GO:0032862 | activation of Rho GTPase activity | 1.040339e-2 |
GO:0030100 | regulation of endocytosis | 1.042617e-2 |
GO:0002432 | granuloma formation | 1.063047e-2 |
GO:0090140 | regulation of mitochondrial fission | 1.063047e-2 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.063047e-2 |
GO:0071502 | cellular response to temperature stimulus | 1.065948e-2 |
GO:0097152 | mesenchymal cell apoptosis | 1.065948e-2 |
GO:0042664 | negative regulation of endodermal cell fate specification | 1.065948e-2 |
GO:0071104 | response to interleukin-9 | 1.065948e-2 |
GO:0002380 | immunoglobulin secretion involved in immune response | 1.065948e-2 |
GO:0003029 | detection of hypoxic conditions in blood by carotid body chemoreceptor signaling | 1.065948e-2 |
GO:0003273 | cell migration involved in endocardial cushion formation | 1.065948e-2 |
GO:0014827 | intestine smooth muscle contraction | 1.065948e-2 |
GO:0043547 | positive regulation of GTPase activity | 1.069904e-2 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 1.083486e-2 |
GO:0034276 | kynurenic acid biosynthetic process | 1.099014e-2 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 1.099014e-2 |
GO:0019556 | histidine catabolic process to glutamate and formamide | 1.099014e-2 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 1.099014e-2 |
GO:0002534 | cytokine production involved in inflammatory response | 1.099014e-2 |
GO:0003259 | cardioblast anterior-lateral migration | 1.099014e-2 |
GO:0003210 | cardiac atrium formation | 1.099014e-2 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 1.099014e-2 |
GO:0003236 | sinus venosus morphogenesis | 1.099014e-2 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.132324e-2 |
GO:0070846 | Hsp90 deacetylation | 1.135673e-2 |
GO:0090042 | tubulin deacetylation | 1.135673e-2 |
GO:0034162 | toll-like receptor 9 signaling pathway | 1.135673e-2 |
GO:0032782 | bile acid secretion | 1.135673e-2 |
GO:0034138 | toll-like receptor 3 signaling pathway | 1.135673e-2 |
GO:0003096 | renal sodium ion transport | 1.135673e-2 |
GO:0015747 | urate transport | 1.144890e-2 |
GO:0008612 | peptidyl-lysine modification to hypusine | 1.144890e-2 |
GO:0071872 | cellular response to epinephrine stimulus | 1.160927e-2 |
GO:0070842 | aggresome assembly | 1.160927e-2 |
GO:0002579 | positive regulation of antigen processing and presentation | 1.173040e-2 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 1.177138e-2 |
GO:0070233 | negative regulation of T cell apoptosis | 1.192704e-2 |
GO:0033235 | positive regulation of protein sumoylation | 1.214177e-2 |
GO:0035434 | copper ion transmembrane transport | 1.214177e-2 |
GO:0060177 | regulation of angiotensin metabolic process | 1.229003e-2 |
GO:0046322 | negative regulation of fatty acid oxidation | 1.243217e-2 |
GO:0061013 | regulation of mRNA catabolic process | 1.262599e-2 |
GO:0008354 | germ cell migration | 1.271276e-2 |
GO:0051693 | actin filament capping | 1.273729e-2 |
GO:0046320 | regulation of fatty acid oxidation | 1.274090e-2 |
GO:0060286 | flagellar cell motility | 1.279273e-2 |
GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 1.279273e-2 |
GO:0071422 | succinate transmembrane transport | 1.279273e-2 |
GO:0070256 | negative regulation of mucus secretion | 1.279273e-2 |
GO:0006601 | creatine biosynthetic process | 1.279273e-2 |
GO:0006994 | positive regulation of transcription via sterol regulatory element binding involved in ER-nuclear sterol response pathway | 1.279273e-2 |
GO:0015891 | siderophore transport | 1.279273e-2 |
GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep | 1.279273e-2 |
GO:0003093 | regulation of glomerular filtration | 1.302178e-2 |
GO:0072044 | collecting duct development | 1.311787e-2 |
GO:0006694 | steroid biosynthetic process | 1.336744e-2 |
GO:0045995 | regulation of embryonic development | 1.343036e-2 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.355984e-2 |
GO:2000425 | regulation of apoptotic cell clearance | 1.368502e-2 |
GO:0014056 | regulation of acetylcholine secretion | 1.368502e-2 |
GO:0051261 | protein depolymerization | 1.368502e-2 |
GO:0042396 | phosphagen biosynthetic process | 1.398254e-2 |
GO:0090116 | C-5 methylation of cytosine | 1.398254e-2 |
GO:0035166 | post-embryonic hemopoiesis | 1.398254e-2 |
GO:0019058 | viral infectious cycle | 1.404975e-2 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.415748e-2 |
GO:0001881 | receptor recycling | 1.415748e-2 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 1.415748e-2 |
GO:0043300 | regulation of leukocyte degranulation | 1.424075e-2 |
GO:0032353 | negative regulation of hormone biosynthetic process | 1.426324e-2 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 1.431633e-2 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 1.439236e-2 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.459647e-2 |
GO:0030834 | regulation of actin filament depolymerization | 1.482856e-2 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 1.486061e-2 |
GO:0061034 | olfactory bulb mitral cell layer development | 1.494363e-2 |
GO:0071436 | sodium ion export | 1.494363e-2 |
GO:0006288 | base-excision repair, DNA ligation | 1.494363e-2 |
GO:0006344 | maintenance of chromatin silencing | 1.494363e-2 |
GO:0060466 | activation of meiosis involved in egg activation | 1.502990e-2 |
GO:0006030 | chitin metabolic process | 1.502990e-2 |
GO:0019722 | calcium-mediated signaling | 1.507700e-2 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 1.535339e-2 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 1.535339e-2 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 1.535339e-2 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 1.535339e-2 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 1.535339e-2 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 1.535339e-2 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 1.535339e-2 |
GO:0030421 | defecation | 1.535339e-2 |
GO:0010625 | positive regulation of Schwann cell proliferation | 1.535339e-2 |
GO:0034635 | glutathione transport | 1.535339e-2 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 1.535339e-2 |
GO:0090007 | regulation of mitotic anaphase | 1.535339e-2 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.535339e-2 |
GO:0015696 | ammonium transport | 1.545355e-2 |
GO:0016090 | prenol metabolic process | 1.561303e-2 |
GO:0009798 | axis specification | 1.576356e-2 |
GO:0006284 | base-excision repair | 1.597048e-2 |
GO:0072111 | cell proliferation involved in kidney development | 1.604129e-2 |
GO:0021697 | cerebellar cortex formation | 1.606045e-2 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 1.619261e-2 |
GO:0070634 | transepithelial ammonium transport | 1.631916e-2 |
GO:0007288 | sperm axoneme assembly | 1.631916e-2 |
GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein | 1.631916e-2 |
GO:0009150 | purine ribonucleotide metabolic process | 1.650005e-2 |
GO:0016458 | gene silencing | 1.678320e-2 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.701595e-2 |
GO:0018243 | protein O-linked glycosylation via threonine | 1.728430e-2 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 1.728430e-2 |
GO:0018242 | protein O-linked glycosylation via serine | 1.728430e-2 |
GO:0018065 | protein-cofactor linkage | 1.728430e-2 |
GO:0009166 | nucleotide catabolic process | 1.734116e-2 |
GO:0043968 | histone H2A acetylation | 1.744020e-2 |
GO:0072172 | mesonephric tubule formation | 1.750774e-2 |
GO:0035089 | establishment of apical/basal cell polarity | 1.750774e-2 |
GO:0071874 | cellular response to norepinephrine stimulus | 1.754952e-2 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 1.762627e-2 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 1.762627e-2 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 1.762627e-2 |
GO:0040019 | positive regulation of embryonic development | 1.815229e-2 |
GO:0072171 | mesonephric tubule morphogenesis | 1.819747e-2 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.834410e-2 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 1.834410e-2 |
GO:0035752 | lysosomal lumen pH elevation | 1.834410e-2 |
GO:0008611 | ether lipid biosynthetic process | 1.834410e-2 |
GO:0032342 | aldosterone biosynthetic process | 1.834410e-2 |
GO:0000046 | autophagic vacuole fusion | 1.834410e-2 |
GO:0001575 | globoside metabolic process | 1.834410e-2 |
GO:0042267 | natural killer cell mediated cytotoxicity | 1.879717e-2 |
GO:0002643 | regulation of tolerance induction | 1.950622e-2 |
GO:0008078 | mesodermal cell migration | 1.968127e-2 |
GO:0070366 | regulation of hepatocyte differentiation | 1.969963e-2 |
GO:0060433 | bronchus development | 1.989908e-2 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 2.000365e-2 |
GO:0007017 | microtubule-based process | 2.010731e-2 |
GO:0090002 | establishment of protein localization in plasma membrane | 2.014750e-2 |
GO:0045819 | positive regulation of glycogen catabolic process | 2.014750e-2 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 2.074628e-2 |
GO:0006195 | purine nucleotide catabolic process | 2.093139e-2 |
GO:0045218 | zonula adherens maintenance | 2.095420e-2 |
GO:0048599 | oocyte development | 2.112307e-2 |
GO:0048842 | positive regulation of axon extension involved in axon guidance | 2.112611e-2 |
GO:0060988 | lipid tube assembly | 2.112611e-2 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 2.112611e-2 |
GO:0072655 | establishment of protein localization in mitochondrion | 2.122506e-2 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 2.144624e-2 |
GO:0021547 | midbrain-hindbrain boundary initiation | 2.162783e-2 |
GO:0021754 | facial nucleus development | 2.162783e-2 |